Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: CMason who wrote (4188)	1/12/1999 5:18:00 PM
From: Bill Wexler	Read Replies (3) \| Respond to of 4634

<<Any idea what's causing the persistent strength in HEPH?>> Hype. Biotech frauds can be very longlived. You have to look at shorting them almost like buying a bond. There is no free lunch when shorting a scam like HEPH or Zonagen. You get the certainty that these companies are not going to change the laws of physics and chemistry - so they'll never sell their quack medicines...but you pay for that certainty with the risk of long-term stock fraud as naive and scientifically illiterate investors are suckered in and the stock price artificially inflated.